These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25306391)

  • 1. Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells.
    Dzeng RK; Jha HC; Lu J; Saha A; Banerjee S; Robertson ES
    Mol Oncol; 2015 Feb; 9(2):365-76. PubMed ID: 25306391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of B-cell exosome proteins by gamma herpesvirus infection.
    Meckes DG; Gunawardena HP; Dekroon RM; Heaton PR; Edwards RH; Ozgur S; Griffith JD; Damania B; Raab-Traub N
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):E2925-33. PubMed ID: 23818640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo.
    Keller SA; Hernandez-Hopkins D; Vider J; Ponomarev V; Hyjek E; Schattner EJ; Cesarman E
    Blood; 2006 Apr; 107(8):3295-302. PubMed ID: 16380446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives
    Wang Y; Ungerleider N; Hoffman BA; Kara M; Farrell PJ; Flemington EK; Lee N; Tibbetts SA
    mBio; 2022 Jun; 13(3):e0083622. PubMed ID: 35642944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB signaling modulation by EBV and KSHV.
    de Oliveira DE; Ballon G; Cesarman E
    Trends Microbiol; 2010 Jun; 18(6):248-57. PubMed ID: 20452220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
    J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells.
    Kawada JI; Ando S; Torii Y; Watanabe T; Sato Y; Ito Y; Kimura H
    Cancer Med; 2018 Apr; 7(4):1275-1284. PubMed ID: 29522278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
    Chen J; Schaller S; Jardetzky TS; Longnecker R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
    Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
    J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Jun; 161(6):447-68. PubMed ID: 23523954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas.
    Hatton O; Phillips LK; Vaysberg M; Hurwich J; Krams SM; Martinez OM
    J Biol Chem; 2011 Oct; 286(43):37368-78. PubMed ID: 21908615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.
    Arvanitakis L; Mesri EA; Nador RG; Said JW; Asch AS; Knowles DM; Cesarman E
    Blood; 1996 Oct; 88(7):2648-54. PubMed ID: 8839859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Therapy for EBV-Associated B-cell Neoplasms.
    Ganguly S; Kuravi S; Alleboina S; Mudduluru G; Jensen RA; McGuirk JP; Balusu R
    Mol Cancer Res; 2019 Apr; 17(4):839-844. PubMed ID: 30487243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Are Maintained Together to Transform the Same B-Cell.
    Sugden AU; Hayes M; Sugden B
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
    Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
    Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.